With the Corporate COVID-19 Antibody Testing Program, EUROIMMUN gives companies the possibility to offer to their staff what EUROIMMUN has already offered to their own employees: an easy, well-organised option to check their Anti-SARS-CoV-2 antibody titers for free following infection or two vaccinations. Considering the alarmingly high number of COVID-19 cases in Germany and other […]
Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 11th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany Fungal cultures and their aesthetically pleasing structures will always hold a special place in my heart, but even I must admit that the introduction of PCR into
Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rapidly increasing in incidence or geographic range. The term also covers diseases that are caused by novel pathogens. These have developed from bacteria or viruses that were previously harmless
Traditionally, Christmas is the time to reflect on what you have achieved and to turn your attention to those who are less well off. After the very challenging, but also successful last two years, we at EUROIMMUN have decided to support charitable projects for the benefit of disadvantaged children financially at the end of this
In October 2021, the organisation KDIGO (Kidney Disease: Improving Clinical Outcomes) published an updated version of the clinical guideline for the management of patients with glomerulonephritis. This guideline contains recommendations for diagnostics in primary membranous nephropathy, an autoimmune kidney disease that is characterised in most cases by the occurrence of autoantibodies against PLA2R and/or THSD7A. The
